Bank of Montreal’s NRX Pharmaceuticals NRXP Stock Holding History

Bank of Montreal’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35,239	Closed	-$3.64M	–	5017
2019 Q1	$3.64M	Hold	35,239	–	–	﹤0.01%	1341
2018 Q4	$3.59M	Hold	35,239	–	–	﹤0.01%	1238
2018 Q3	$3.53M	Hold	35,239	–	–	﹤0.01%	1377
2018 Q2	$3.49M	Buy	+35,239	New	+$3.48M	﹤0.01%	1351

Other funds holding NRXP

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Bank of Montreal's NRXP Position: Q2 2019 in Review

Bank of Montreal sold out of NRX Pharmaceuticals (NRXP) in Q2 2019, closing a stake of 35,239 shares — an estimated $3.64M sold.

Bank of Montreal first reported a position in NRXP in Q2 2018 and held it in 4 quarters. The position peaked at $3.64M in Q1 2019. 17 funds tracked by Wall St. Rank hold NRXP as of Q2 2019.

Bank of Montreal reported no remaining NRX Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Bank of Montreal sold 35,239 NRX Pharmaceuticals shares in Q2 2019, an estimated $3.64M.
Bank of Montreal first reported a position in NRX Pharmaceuticals in Q2 2018 and held it in 4 quarters.
Bank of Montreal's NRX Pharmaceuticals position peaked at $3.64M in Q1 2019.
17 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2019.

Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.